A MAN who was shot and killed in Seventh Avenue, Malick on Thursday has been identified as Elijah Sambury, 23 who lived near ...

The Upali Group of Companies, together with its employees and sales agents across the country, held religious ceremonies ...

Press release Havre firefighters dealt last week with their second residence fire in two weeks. The Fire Department said in a press release that Feb. 5 at 7:31 a.m. firefighters were dispatched for a ...

Evidence shows that “peak truck” is a U.S. economic trend to watch in 2025 as American consumers struggle with affordability, ...

"TGFB2 has emerged as a master regulator of immune suppression, not just in cancer but across multiple chronic diseases,” said Dr. Trieu. "Our work on OT-101 aims to neutralize TGFB2-driven resistance ...

Proposed work includes installing rectangular rapid flashing beacons and sidewalk curb ramp improvements at key crossings on Last Chance Gulch and South Montana Avenue.

The Nanlux Evoke 5000B is being touted as the world's first 5000W Stormproof LED bi-color spotlight with Green/Magenta ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

During the Buddha’s time, the disciples followed teachings through a practice of carika. They walked barefoot for countless miles, carrying only ...

In a challenging market environment, Marker Therapeutics Inc. (NASDAQ:MRKR) stock has reached a 52-week low, dipping to $1.61. According to InvestingPro analysis, the stock appears undervalued at ...

Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

Brookline initiated coverage of Marker Therapeutics (MRKR) with a Buy rating and $4 price target Marker is a clinical-stage immuno-oncology ...